Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Yasons Chemex Care Ltd

YCCL
NSE
9.80
1.51%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Yasons Chemex Care Ltd

YCCL
NSE
9.80
1.51%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
19Cr
Close
Close Price
9.80
Industry
Industry
Dyes & Pigments
PE
Price To Earnings
35.00
PS
Price To Sales
0.20
Revenue
Revenue
96Cr
Rev Gr TTM
Revenue Growth TTM
57.83%
PAT Gr TTM
PAT Growth TTM
145.16%
Peer Comparison
How does YCCL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
YCCL
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Revenue
RevenueCr
12253832294749
Growth YoY
Revenue Growth YoY%
212.828.0-21.748.767.7
Expenses
ExpensesCr
11253532274848
Operating Profit
Operating ProfitCr
10303-12
OPM
OPM%
6.4-1.17.9-1.28.8-2.83.5
Other Income
Other IncomeCr
3210120
Interest Expense
Interest ExpenseCr
0001111
Depreciation
DepreciationCr
0000000
PBT
PBTCr
314-1301
Tax
TaxCr
1010000
PAT
PATCr
313-2201
Growth YoY
PAT Growth YoY%
4.8-312.2-33.383.4-45.7
NPM
NPM%
22.43.07.5-5.06.4-0.62.1
EPS
EPS
0.00.01.8-1.11.1-0.20.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
37697796
Growth
Revenue Growth%
88.310.526.0
Expenses
ExpensesCr
36677596
Operating Profit
Operating ProfitCr
0310
OPM
OPM%
1.33.81.60.4
Other Income
Other IncomeCr
4132
Interest Expense
Interest ExpenseCr
0111
Depreciation
DepreciationCr
0000
PBT
PBTCr
4221
Tax
TaxCr
1110
PAT
PATCr
3121
Growth
PAT Growth%
-63.629.9-53.1
NPM
NPM%
9.31.82.10.8
EPS
EPS
2.40.70.80.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
141919
Reserves
ReservesCr
72021
Current Liabilities
Current LiabilitiesCr
61518
Non Current Liabilities
Non Current LiabilitiesCr
100
Total Liabilities
Total LiabilitiesCr
285559
Current Assets
Current AssetsCr
205156
Non Current Assets
Non Current AssetsCr
743
Total Assets
Total AssetsCr
285559

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0-16-2
Investing Cash Flow
Investing Cash FlowCr
000
Financing Cash Flow
Financing Cash FlowCr
0181
Net Cash Flow
Net Cash FlowCr
01-1
Free Cash Flow
Free Cash FlowCr
0-16-3
CFO To PAT
CFO To PAT%
-7.8-1,300.3-151.0
CFO To EBITDA
CFO To EBITDA%
-54.6-622.4-194.0

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
05025
Price To Earnings
Price To Earnings
0.039.715.3
Price To Sales
Price To Sales
0.00.70.3
Price To Book
Price To Book
0.01.30.6
EV To EBITDA
EV To EBITDA
6.921.827.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
3.46.23.8
OPM
OPM%
1.33.81.6
NPM
NPM%
9.31.82.1
ROCE
ROCE%
19.16.67.1
ROE
ROE%
16.53.24.0
ROA
ROA%
12.42.32.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Yasons Chemex Care Limited is a Gujarat-based manufacturer and trader specializing in a diversified portfolio of **dyestuffs, chemical intermediates, and Fast-Moving Consumer Goods (FMCG)**. As a subsidiary of **Yash Chemex Limited**, the company operates a vertically integrated model designed to capture value across the chemical supply chain while expanding into high-margin consumer personal care segments. --- ### Integrated Manufacturing & Strategic Infrastructure The company’s operations are strategically concentrated in Gujarat’s premier chemical industrial zones, providing a competitive advantage through shared infrastructure and regulatory ease. | Facility | Location | Strategic Advantage | | :--- | :--- | :--- | | **Unit-1** | Changodar, Sanand, Ahmedabad | Located in Shreeji Krupa Industrial Estate; focused on FMCG and specialty lines. | | **Unit-2** | Vatva, Ahmedabad | Situated in GIDC Phase-2; provides direct access to the **Common Effluent Treatment Plant (CETP)** for efficient waste management. | **Operational Synergy:** Proximity to other chemical manufacturers in Gujarat facilitates **knowledge sharing, collaborative R&D, and optimized transportation** of raw materials. The company prioritizes **sustainability** through advanced waste management initiatives and environmentally friendly manufacturing techniques. --- ### Diversified Product Ecosystem Yasons operates under a single reportable business segment but maintains three distinct product verticals: #### 1. Chemicals & Dyestuffs * **Core Portfolio:** High-quality **dyestuffs, pigment pastes, and chemical intermediates**. * **Market Dominance:** The **Textiles segment** is the primary revenue driver, commanding a **65.6% market share** as of 2024. * **Growth Catalyst:** The **Printing Ink** industry is projected as the fastest-growing segment through **2033**, driven by the superior color density of dye-based inks over pigments. #### 2. FMCG & Personal Care * **Product Range:** Includes **Hair Re-Growth Oil, perfumes, deodorants, hand-made soaps, hand sanitizers, and skincare essentials**. * **Bespoke Manufacturing:** The company has expanded into **customized product manufacturing**, tailoring chemical and FMCG solutions to specific institutional client requirements. #### 3. Trading Operations * **Scope:** Distribution and trading of **all kinds of chemicals**, leveraging the parent company’s network to provide a comprehensive sourcing solution for clients. --- ### Capital Structure & IPO Fund Utilization The company successfully transitioned to the public markets via an **Initial Public Offer (IPO)** on the **NSE EMERGE** platform on **August 3, 2023**. * **Total Funds Raised:** **INR 20.57 Crore** (at **INR 40** per share). * **Capital Expansion:** Post-IPO, paid-up equity share capital increased from **Rs. 14.16 crore** to **Rs. 19.30 crore**. * **Utilization Status:** As of May 2025, issue-related expenses of **Rs. 339.37 lakhs** have been fully utilized. Remaining proceeds are earmarked for scaling manufacturing capacity and strengthening the business footprint. * **Reinvestment Strategy:** Management maintained a **zero dividend payout** for FY 2023-24, transferring **100% of Net Profit (INR 1.24 crore)** to reserves to fund future development. --- ### Financial Performance & Subsidiary Growth Yasons has demonstrated resilience despite global geopolitical volatility and inflationary pressures. **Standalone Financial Summary:** | Metric (Rs. in Crore) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :---: | :---: | :---: | | **Revenue from Operations** | **45.84** | **47.67** | **36.77** | | **EBITDA** | **2.17** | **4.67** | - | | **Profit After Tax (PAT)** | **1.61** | **1.24** | **3.43** | **Subsidiary Performance (Rishit Polysurf LLP):** The company holds a **99% stake** in Rishit Polysurf LLP. This subsidiary is a significant growth engine: * **FY25 H1 Performance:** Reported assets of **₹18.56 crore** and a net profit of **₹29.63 lakhs**. * **Consolidated Impact:** In FY24, consolidated revenue reached **Rs. 69.24 crore**, an **88.30% year-on-year increase**, largely driven by the integration of this subsidiary. --- ### Risk Management & Mitigation Framework The company employs a structured **Risk Management Policy** overseen by the Board and Audit Committee to navigate market uncertainties. #### Financial & Market Risks * **Price Volatility:** Exposure to **Active Pharmaceutical Ingredients (APIs)** and raw material price cycles. The company currently does **not use derivative contracts** for hedging. * **Liquidity & Debt:** Risk is rated **very low**. The company relies on **operating cash flows and equity**. Non-current borrowings were reduced from **Rs. 77.37 lakh** (FY23) to **Rs. 42.08 lakh** (FY24). There are **no short-term bank loans** outstanding. * **Credit Risk:** Managed via a simplified **Expected Credit Loss (ECL) model**; the company has a negligible history of bad debts. #### Employee Benefit Obligations (Gratuity) The company manages long-term liabilities with a weighted average duration of **9.32 years**. Key risks include: * **Actuarial Risk:** Potential for salary growth to exceed assumptions. * **Market Risk:** Sensitivity to the **discount rate** (lower rates increase the Defined Benefit Obligation). * **Legislative Risk:** Potential changes to the **Payment of Gratuity Act**. --- ### Governance & Compliance Outlook While the company maintains a **statutory compliance management system** audited by external chartered accountants, it has identified areas for administrative improvement: * **Compliance Gaps:** In FY 2023-24, the company noted a temporary absence of an **Internal Auditor** and delays in filing certain statutory forms (e-Form MGT 14). * **Transparency:** Management is addressing a noted gap in **Information Technology** updates regarding the corporate website to improve investor communication. * **CSR Status:** Currently exempt from CSR Committee requirements under **Section 135(1)** of the Companies Act. ### Strategic Roadmap Yasons Chemex Care is positioned to capitalize on the fact that the **Indian chemical industry** currently contributes only **3% to global production**, suggesting a significant runway for domestic players. The strategy focuses on **multi-site manufacturing prowess**, **bespoke chemical solutions**, and the transition toward **eco-friendly specialty chemicals** to capture higher market share in both domestic and emerging international markets.